The revenue change in the 'Cold & Cough Remedies' segment of the otc pharmaceuticals market in Singapore was forecast to increase between 2024 and 2029 by in total 0.3 percentage points. This overall increase does not happen continuously, notably not in 2027, 2028 and 2029. The indicator is estimated to amount to 6.01 percent in 2029.
Data provided by Statista Market Insights are estimates.
Definition: The Cold and Cough market comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional Information: The Cold and Cough market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included. For more information on the data displayed, use the info button next to the boxes.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista. (April 8, 2024). Revenue growth of the cold & cough remedies market in Singapore from 2019 to 2029 [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1196410/revenue-growth-cold-and-cough-remedies-singapore
Statista. "Revenue growth of the cold & cough remedies market in Singapore from 2019 to 2029." Chart. April 8, 2024. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1196410/revenue-growth-cold-and-cough-remedies-singapore
Statista. (2024). Revenue growth of the cold & cough remedies market in Singapore from 2019 to 2029. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1196410/revenue-growth-cold-and-cough-remedies-singapore
Statista. "Revenue Growth of The Cold & Cough Remedies Market in Singapore from 2019 to 2029." Statista, Statista Inc., 8 Apr 2024, https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1196410/revenue-growth-cold-and-cough-remedies-singapore
Statista, Revenue growth of the cold & cough remedies market in Singapore from 2019 to 2029 Statista, https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1196410/revenue-growth-cold-and-cough-remedies-singapore (last visited November 10, 2024)
Revenue growth of the cold & cough remedies market in Singapore from 2019 to 2029 [Graph], Statista, April 8, 2024. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1196410/revenue-growth-cold-and-cough-remedies-singapore